Last updated on August 2020

Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients


Brief description of study

The purpose of this study is to support the dose selection for future studies by evaluating efficacy and safety of different QBW251 doses in COPD patients with chronic bronchitis and a history of exacerbations, compared to placebo, when added to a triple combination therapy of LABA, LAMA and ICS with respect to trough FEV1 change from baseline after 12 weeks of treatment.

Clinical Study Identifier: NCT04072887

Find a site near you

Start Over

Novartis Investigative Site

Andalusia, AL United States
  Connect »

Novartis Investigative Site

Los Angeles, CA United States
  Connect »

Novartis Investigative Site

Westminster, CA United States
  Connect »

Novartis Investigative Site

Boulder, CO United States
  Connect »

Novartis Investigative Site

Ormond Beach, FL United States
  Connect »

Novartis Investigative Site

Winter Park, FL United States
  Connect »

Novartis Investigative Site

River Forest, IL United States
  Connect »

Novartis Investigative Site

Florence, KY United States
  Connect »

Novartis Investigative Site

New Orleans, LA United States
  Connect »

Novartis Investigative Site

Livonia, MI United States
  Connect »

Novartis Investigative Site

Saint Louis, MO United States
  Connect »

Novartis Investigative Site

Charlotte, NC United States
  Connect »

Novartis Investigative Site

Gastonia, NC United States
  Connect »

Novartis Investigative Site

Columbus, OH United States
  Connect »

Novartis Investigative Site

South Brisbane, Australia
  Connect »

Novartis Investigative Site

San Diego, CA United States
  Connect »

Novartis Investigative Site

Crowley, LA United States
  Connect »

Novartis Investigative Site

Minneapolis, MN United States
  Connect »

Novartis Investigative Site

Saint Charles, MO United States
  Connect »

Novartis Investigative Site

Medford, OR United States
  Connect »

Novartis Investigative Site

El Paso, TX United States
  Connect »

Novartis Investigative Site

Houston, TX United States
  Connect »

Novartis Investigative Site

McKinney, TX United States
  Connect »

Novartis Investigative Site

Thalheim bei Wels, Austria
  Connect »

Novartis Investigative Site

St-Charles-Borromee, QC Canada
  Connect »

Novartis Investigative Site

Higashiibaraki-gun, Japan
  Connect »

Novartis Investigative Site

Seoul, Korea, Republic of
  Connect »

Novartis Investigative Site

Spisska Nova Ves, Slovakia
  Connect »

Novartis Investigative Site

Sarasota, FL United States
  Connect »

Novartis Investigative Site

Zachary, LA United States
  Connect »

Novartis Investigative Site

Midlothian, VA United States
  Connect »

Novartis Investigative Site

Concepcion del Uruguay, Argentina
  Connect »

Novartis Investigative Site

Ciudad Autonoma de Bs As, Argentina
  Connect »

Novartis Investigative Site

Montpellier cedex 5, France
  Connect »

Novartis Investigative Site

Guatemala City, Guatemala
  Connect »

Novartis Investigative Site

New Territories, Hong Kong
  Connect »

Novartis Investigative Site

Wonju, Korea, Republic of
  Connect »

Novartis Investigative Site

Daegu, Korea, Republic of
  Connect »

Novartis Investigative Site

Incheon, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.